Compound Detail
CHEMBL11
IMIPRAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL11 |
| Name | IMIPRAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | BCGWQEUPMDMJNV-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
50
Targets
143
Activities
4
Assay Types
30
PK Parameters
20
Publications
10
Known Names
18
Indications
Molecular Properties
280.4
MW (Da)
3.88
ALogP
2
HBA
0
HBD
6.5
PSA (Ų)
0.84
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1959 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Depressive Disorder Depressive Disorder Anxiety Chest Pain Death, Sudden, Cardiac Dementia Digestive System Diseases Gastroesophageal Reflux Low Back Pain Myocardial Infarction Schizophrenia Urinary Incontinence, Stress Ventricular Fibrillation Rosacea Somatoform Disorders Dysthymic Disorder Photosensitivity Disorders Breast Neoplasms
ATC Classification
N06AA02
imipramine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 92 meas. best 10.22
Ki 45 meas. best 9.28
EC50 4 meas. best 6.52
Kd 2 meas. best 8.9
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histamine H1 receptor CHEMBL4701 | IC50 | 10.22 | 10.22 | 0.1 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 9.28 | 8.2944 | 0.5 | 16 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 9.06 | 8.368 | 0.9 | 15 |
| Serotonin (5-HT) receptor CHEMBL2096904 | Ki | 8.96 | 8.96 | 1.1 | 1 |
| Serotonin (5-HT) receptor CHEMBL2096904 | IC50 | 8.96 | 8.96 | 1.1 | 1 |
| Ileum CHEMBL613680 | Kd | 8.9 | 8.9 | 1.3 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 8.77 | 8.77 | 1.7 | 1 |
| Sodium-dependent serotonin transporter CHEMBL4642 | Ki | 8.3 | 7.84 | 5.0 | 2 |
| Histamine H1 receptor CHEMBL231 | Ki | 8.0 | 8.0 | 10.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 7.92 | 7.1733 | 12.0 | 3 |
| Norepinephrine transporter CHEMBL304 | Ki | 7.92 | 7.92 | 12.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL2370 | Ki | 7.92 | 7.86 | 12.0 | 2 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 7.8 | 7.8 | 16.0 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 7.64 | 7.64 | 23.0 | 1 |
| Histamine H1 receptor CHEMBL231 | IC50 | 7.57 | 7.57 | 27.0 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.57 | 6.2895 | 27.0 | 19 |
| Sodium-dependent serotonin transporter CHEMBL313 | Ki | 7.54 | 7.4867 | 29.0 | 3 |
| Unchecked CHEMBL612545 | IC50 | 7.52 | 6.054 | 30.0 | 5 |
| Serotonin (5-HT) receptor CHEMBL2094123 | IC50 | 7.36 | 7.36 | 44.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 7.34 | 7.0 | 46.0 | 2 |
| Norepinephrine transporter CHEMBL304 | IC50 | 7.22 | 6.5633 | 60.0 | 3 |
| Sodium-dependent serotonin transporter CHEMBL313 | IC50 | 7.21 | 6.685 | 61.0 | 4 |
| Muscarinic acetylcholine receptor CHEMBL1907609 | Ki | 7.19 | 7.19 | 65.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 7.13 | 7.13 | 74.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 7.03 | 6.915 | 94.0 | 2 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 6.8 | 6.8 | 160.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 6.8 | 6.8 | 160.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL3006 | Ki | 6.8 | 6.8 | 160.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 6.66 | 6.66 | 220.0 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Ki | 6.59 | 5.95 | 255.0 | 2 |
| Muscarinic acetylcholine receptor CHEMBL1907609 | IC50 | 6.57 | 6.57 | 269.0 | 1 |
| Mus musculus CHEMBL375 | EC50 | 6.52 | 6.205 | 300.0 | 2 |
| Muscarinic acetylcholine receptor M5 CHEMBL277 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL3602 | Ki | 6.46 | 6.46 | 343.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 6.39 | 6.39 | 410.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL1743122 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
| Dopamine receptor CHEMBL2093868 | IC50 | 6.19 | 6.19 | 645.0 | 1 |
| D(2) dopamine receptor CHEMBL3427 | Ki | 6.14 | 6.14 | 726.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 6.14 | 6.14 | 726.0 | 1 |
| Histamine H2 receptor CHEMBL2882 | IC50 | 5.72 | 5.72 | 1900.0 | 1 |
| Sigma intracellular receptor 2 CHEMBL4105864 | Ki | 5.68 | 5.68 | 2107.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.47 | 5.47 | 3388.4 | 8 |
| Sodium channel alpha subunit CHEMBL2331043 | IC50 | 5.44 | 5.44 | 3600.0 | 1 |
| Sodium channel alpha subunits; brain (Types I, II, III) CHEMBL2096682 | IC50 | 5.44 | 5.44 | 3600.0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C CHEMBL3762 | IC50 | 5.39 | 5.235 | 4050.0 | 2 |
| Sphingomyelin phosphodiesterase CHEMBL2760 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| ScN2a CHEMBL613872 | EC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Solute carrier family 22 member 1 CHEMBL5685 | IC50 | 5.1 | 4.7667 | 7950.0 | 3 |
| Voltage-gated L-type calcium channel CHEMBL2095229 | IC50 | 5.08 | 5.08 | 8300.0 | 1 |
| Major prion protein CHEMBL4869 | EC50 | 5.0 | 5.0 | 10000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 9.46 | mL.min-1.kg-1 | Homo sapiens |
| CL | 13.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 13.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.62 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 13.49 | mL.min-1.g-1 | Homo sapiens |
| CL | 150.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 1.2e-05 | mL.min-1.g-1 | Homo sapiens |
| CL | - | - | Homo sapiens |
| CL | 299.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 86.8 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 23.6 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 13.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.012 | uL/min | Homo sapiens |
| CL | 0.038 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.038 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.038 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.0511 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.0396 | mL.min-1.g-1 | Homo sapiens |
| CL | 115.5 | mL.min-1.g-1 | Homo sapiens |
| CL | 79.5 | mL.min-1.g-1 | Homo sapiens |
| CL | 125.5 | mL.min-1.g-1 | Mus musculus |
| CL | 616.9 | mL.min-1.kg-1 | Homo sapiens |
| CL | 202.0 | mL.min-1.g-1 | Mus musculus |
| CL | 687.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 7.8 | mL.min-1.g-1 | Homo sapiens |
| CL | 115.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 22.8 | mL.min-1.g-1 | Homo sapiens |
| CL | 113.7 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 104.1 | mL.min-1.g-1 | Rattus norvegicus |
| Cmax | 710.0 | nM | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885861 | Rattus norvegicus | 1404 |
| 23378628 | 10.1124/dmd.112.050054 | ADMET | 16 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 7328600 | 10.1021/jm00140a013 | Rattus norvegicus | 12 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 10649973 | 10.1021/jm980333v | Mus musculus | 10 |
| 19679379 | 10.1016/j.ejmech.2009.07.014 | Mus musculus | 9 |
| 6103958 | 10.1021/jm00178a009 | Mus musculus | 9 |
| 17418579 | 10.1016/j.bmc.2007.03.040 | ADMET | 9 |
| 1335075 | 10.1021/jm00102a004 | Mus musculus | 9 |
| 17517514 | 10.1016/j.bmc.2007.05.017 | Mus musculus | 9 |
| 6103959 | 10.1021/jm00178a010 | Mus musculus | 9 |
| 6167716 | 10.1021/jm00135a006 | ADMET | 8 |
| 1246052 | 10.1021/jm00223a010 | Mus musculus | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 7265119 | 10.1021/jm00135a018 | Mus musculus | 7 |
| 6716399 | 10.1021/jm00371a011 | Mus musculus | 7 |
| 17321139 | 10.1016/j.bmc.2007.02.018 | Mus musculus | 6 |
| 20060623 | 10.1016/j.ejmech.2009.11.053 | Mus musculus | 6 |
| 4067998 | 10.1021/jm00149a031 | Mus musculus | 6 |
Data from ChEMBL 36 via Core Engine